Demonstration of a melanoma-specific CD44 alternative splicing pattern that remains qualitatively stable, but shows quantitative changes during tumour progression

证实黑色素瘤特异性 CD44 选择性剪接模式在定性上保持稳定，但在肿瘤进展过程中会发生定量变化。